Dr. Juan Vilaro, M.D
NPI: 1033316948
Total Payments
$1,857
2024 Payments
$219.32
Companies
8
Transactions
17
Medicare Patients
14,248
Medicare Billing
$577,079
Payment Breakdown by Category
Travel$936.38 (50.4%)
Food & Beverage$877.37 (47.3%)
Education$42.80 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $936.38 | 3 | 50.4% |
| Food and Beverage | $877.37 | 13 | 47.3% |
| Education | $42.80 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,150 | 7 | $0 (2024) |
| ABIOMED | $329.78 | 4 | $0 (2024) |
| Abbott Laboratories | $142.48 | 1 | $0 (2017) |
| Medtronic Vascular, Inc. | $108.07 | 1 | $0 (2019) |
| NeoTract Inc. | $55.32 | 1 | $0 (2020) |
| Teleflex LLC | $32.42 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $27.75 | 1 | $0 (2023) |
| PFIZER INC. | $10.94 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $219.32 | 2 | ABIOMED ($115.91) |
| 2023 | $60.17 | 2 | Teleflex LLC ($32.42) |
| 2021 | $213.87 | 3 | ABIOMED ($213.87) |
| 2020 | $55.32 | 1 | NeoTract Inc. ($55.32) |
| 2019 | $119.01 | 2 | Medtronic Vascular, Inc. ($108.07) |
| 2018 | $1,046 | 6 | Merck Sharp & Dohme Corporation ($1,046) |
| 2017 | $142.48 | 1 | Abbott Laboratories ($142.48) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $103.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/27/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $115.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/30/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $32.42 | General |
| Category: Interventional Urology | ||||||
| 10/29/2021 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $131.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2021 | ABIOMED | Impella (Device) | Education | In-kind items and services | $42.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2021 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $39.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $55.32 | General |
| Category: Interventional Urology | ||||||
| 09/13/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/15/2019 | Medtronic Vascular, Inc. | Amplia MRI (Device) | Food and Beverage | In-kind items and services | $108.07 | General |
| Category: Cardiac Resynchronization Therapy - CRT | ||||||
| 05/04/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Travel and Lodging | In-kind items and services | $265.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/03/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Travel and Lodging | In-kind items and services | $406.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/03/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Travel and Lodging | In-kind items and services | $265.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/08/2017 | Abbott Laboratories | Circulatory Support (Device) | Food and Beverage | In-kind items and services | $142.48 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,463 | 3,623 | $488,654 | $85,803 |
| 2022 | 17 | 2,793 | 4,310 | $748,375 | $132,279 |
| 2021 | 18 | 2,963 | 4,980 | $809,229 | $150,933 |
| 2020 | 18 | 6,029 | 11,827 | $1.2M | $208,063 |
Total Patients
14,248
Total Services
24,740
Medicare Billing
$577,079
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,840 | 2,768 | $127,328 | $17,339 | 13.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 87 | 102 | $65,828 | $12,126 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 124 | $57,216 | $12,001 | 21.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 49 | 133 | $36,335 | $8,366 | 23.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 75 | 78 | $37,611 | $7,728 | 20.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 66 | $27,375 | $6,245 | 22.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 26 | 26 | $28,099 | $3,713 | 13.2% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 25 | 30 | $22,620 | $2,952 | 13.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $11,201 | $2,368 | 21.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 35 | 35 | $12,219 | $2,338 | 19.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 43 | 43 | $16,492 | $2,292 | 13.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 14 | $9,153 | $1,930 | 21.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 32 | 45 | $7,773 | $1,793 | 23.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 25 | 25 | $7,031 | $1,597 | 22.7% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 12 | 44 | $10,157 | $1,427 | 14.1% |
| 93750 | Evaluation of lower heart chamber assist device | Office | 2023 | 13 | 25 | $7,178 | $973.93 | 13.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 25 | 29 | $2,640 | $296.67 | 11.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 11 | 11 | $1,521 | $194.30 | 12.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $877.00 | $123.41 | 14.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 167 | 249 | $160,493 | $30,484 | 19.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 95 | 321 | $117,756 | $25,672 | 21.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 1,983 | 3,063 | $140,898 | $19,915 | 14.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 85 | 93 | $66,150 | $14,337 | 21.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 84 | 86 | $41,718 | $9,155 | 21.9% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 36 | 42 | $31,694 | $4,055 | 12.8% |
About Dr. Juan Vilaro, M.D
Dr. Juan Vilaro, M.D is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1033316948.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Juan Vilaro, M.D has received a total of $1,857 in payments from pharmaceutical and medical device companies, with $219.32 received in 2024. These payments were reported across 17 transactions from 8 companies. The most common payment nature is "Travel and Lodging" ($936.38).
As a Medicare-enrolled provider, Vilaro has provided services to 14,248 Medicare beneficiaries, totaling 24,740 services with total Medicare billing of $577,079. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Other Specialties Cardiovascular Disease, Internal Medicine
- Location Gainesville, FL
- Active Since 07/03/2007
- Last Updated 12/18/2025
- Taxonomy Code 207RA0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033316948
Products in Payments
- MK-1242 (Drug) $1,046
- Impella (Device) $329.78
- Circulatory Support (Device) $142.48
- Amplia MRI (Device) $108.07
- VERQUVO (Drug) $103.41
- UroLift (Device) $55.32
- UROLIFT (Device) $32.42
- XARELTO (Drug) $27.75
- VYNDAQEL (Drug) $10.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Advanced Heart Failure and Transplant Cardiology Doctors in Gainesville
Dr. Ugochukwu Egolum, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $182,476
Advanced Heart Failure and Transplant Cardiology $182,476
Amit Badiye, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $26,170
Advanced Heart Failure and Transplant Cardiology $26,170
Dr. Alison Bailey, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $17,791
Advanced Heart Failure and Transplant Cardiology $17,791
Dr. Giancarlo Acosta, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $9,282
Advanced Heart Failure and Transplant Cardiology $9,282
Dr. Nitya Chandra, Md, MD
Advanced Heart Failure and Transplant Cardiology — Payments: $4,181
Advanced Heart Failure and Transplant Cardiology $4,181
Lawrence Charles, M.d, M.D
Advanced Heart Failure and Transplant Cardiology — Payments: $2,745
Advanced Heart Failure and Transplant Cardiology $2,745